Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 15 | 2025 | 1583 | 2.760 |
Why?
|
| Diagnostic Imaging | 7 | 2023 | 176 | 2.110 |
Why?
|
| Soft Tissue Neoplasms | 3 | 2020 | 62 | 1.610 |
Why?
|
| Amyloidosis | 5 | 2016 | 83 | 1.500 |
Why?
|
| Wrist Joint | 2 | 2025 | 11 | 1.330 |
Why?
|
| Sarcoma | 3 | 2020 | 72 | 1.310 |
Why?
|
| Arthralgia | 3 | 2025 | 44 | 1.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 4 | 2016 | 64 | 1.030 |
Why?
|
| Caenorhabditis elegans | 2 | 2024 | 131 | 0.950 |
Why?
|
| Wrist Injuries | 1 | 2025 | 11 | 0.910 |
Why?
|
| Pelvic Organ Prolapse | 3 | 2021 | 28 | 0.830 |
Why?
|
| Joint Diseases | 2 | 2014 | 40 | 0.820 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2024 | 59 | 0.820 |
Why?
|
| Pelvis | 3 | 2020 | 66 | 0.800 |
Why?
|
| Physical Examination | 2 | 2014 | 96 | 0.800 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 120 | 0.780 |
Why?
|
| Tendons | 1 | 2023 | 26 | 0.780 |
Why?
|
| Lower Extremity | 1 | 2023 | 103 | 0.730 |
Why?
|
| Pelvic Floor | 3 | 2021 | 53 | 0.690 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2016 | 98 | 0.660 |
Why?
|
| Algorithms | 2 | 2014 | 667 | 0.640 |
Why?
|
| Abdominal Neoplasms | 1 | 2020 | 16 | 0.640 |
Why?
|
| Pelvic Neoplasms | 1 | 2020 | 14 | 0.630 |
Why?
|
| Contrast Media | 3 | 2016 | 178 | 0.620 |
Why?
|
| Bone Marrow Transplantation | 2 | 2016 | 110 | 0.560 |
Why?
|
| Cartilage Diseases | 1 | 2018 | 11 | 0.560 |
Why?
|
| Menisci, Tibial | 1 | 2018 | 11 | 0.550 |
Why?
|
| Musculoskeletal Diseases | 2 | 2024 | 51 | 0.550 |
Why?
|
| Osteoarthritis | 1 | 2018 | 61 | 0.530 |
Why?
|
| Suburethral Slings | 1 | 2016 | 13 | 0.500 |
Why?
|
| Surgical Mesh | 1 | 2016 | 18 | 0.500 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2016 | 32 | 0.490 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2017 | 1180 | 0.490 |
Why?
|
| Gadolinium | 1 | 2016 | 47 | 0.490 |
Why?
|
| Humans | 34 | 2025 | 53230 | 0.460 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 191 | 0.440 |
Why?
|
| Image Enhancement | 2 | 2014 | 49 | 0.430 |
Why?
|
| Neurofibroma | 1 | 2014 | 18 | 0.430 |
Why?
|
| Ankle Joint | 1 | 2014 | 22 | 0.420 |
Why?
|
| Heart Diseases | 1 | 2016 | 221 | 0.410 |
Why?
|
| Elbow Joint | 1 | 2014 | 17 | 0.410 |
Why?
|
| Shoulder Joint | 1 | 2014 | 40 | 0.410 |
Why?
|
| Hip Joint | 1 | 2014 | 59 | 0.410 |
Why?
|
| Myocardium | 2 | 2016 | 471 | 0.400 |
Why?
|
| Knee Joint | 1 | 2014 | 166 | 0.380 |
Why?
|
| Biopsy | 4 | 2017 | 600 | 0.340 |
Why?
|
| Pelvic Pain | 1 | 2010 | 18 | 0.330 |
Why?
|
| Varicose Veins | 1 | 2010 | 18 | 0.330 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 72 | 0.320 |
Why?
|
| Ovary | 1 | 2010 | 103 | 0.320 |
Why?
|
| Abdomen | 2 | 2020 | 71 | 0.310 |
Why?
|
| Postoperative Complications | 1 | 2016 | 1099 | 0.290 |
Why?
|
| Finger Injuries | 1 | 2008 | 8 | 0.280 |
Why?
|
| Tendon Injuries | 1 | 2008 | 15 | 0.280 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 502 | 0.270 |
Why?
|
| Female | 17 | 2024 | 28782 | 0.260 |
Why?
|
| Fractures, Bone | 1 | 2008 | 106 | 0.260 |
Why?
|
| Middle Aged | 12 | 2024 | 13419 | 0.250 |
Why?
|
| Predictive Value of Tests | 4 | 2016 | 934 | 0.220 |
Why?
|
| Male | 15 | 2024 | 27435 | 0.210 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 291 | 0.210 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2024 | 83 | 0.200 |
Why?
|
| Longevity | 1 | 2024 | 85 | 0.200 |
Why?
|
| Forkhead Transcription Factors | 1 | 2024 | 120 | 0.200 |
Why?
|
| Zebrafish | 1 | 2022 | 61 | 0.190 |
Why?
|
| Diagnosis, Differential | 4 | 2016 | 1038 | 0.180 |
Why?
|
| Insulin | 1 | 2024 | 493 | 0.170 |
Why?
|
| Retrospective Studies | 7 | 2024 | 6819 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 1723 | 0.170 |
Why?
|
| Pelvic Floor Disorders | 1 | 2021 | 29 | 0.170 |
Why?
|
| Radiology Information Systems | 2 | 2024 | 32 | 0.160 |
Why?
|
| Elbow | 1 | 2019 | 14 | 0.150 |
Why?
|
| Aging | 1 | 2024 | 714 | 0.150 |
Why?
|
| Time Factors | 2 | 2016 | 2991 | 0.140 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2018 | 60 | 0.140 |
Why?
|
| Treatment Outcome | 5 | 2016 | 5595 | 0.130 |
Why?
|
| Tissue Transplantation | 1 | 2017 | 8 | 0.130 |
Why?
|
| Muscle Neoplasms | 1 | 2017 | 17 | 0.130 |
Why?
|
| Software | 2 | 2016 | 280 | 0.130 |
Why?
|
| Neurilemmoma | 1 | 2017 | 25 | 0.130 |
Why?
|
| Adult | 7 | 2024 | 14534 | 0.130 |
Why?
|
| Radiography | 1 | 2018 | 476 | 0.130 |
Why?
|
| Bile Duct Diseases | 1 | 2016 | 10 | 0.120 |
Why?
|
| Prognosis | 3 | 2016 | 2118 | 0.120 |
Why?
|
| Hepatic Artery | 1 | 2016 | 21 | 0.120 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 29 | 0.120 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 26 | 0.120 |
Why?
|
| Thoracic Diseases | 1 | 2016 | 9 | 0.120 |
Why?
|
| Free Tissue Flaps | 1 | 2017 | 63 | 0.120 |
Why?
|
| Lymphatic Diseases | 1 | 2016 | 23 | 0.120 |
Why?
|
| Skin | 1 | 2019 | 419 | 0.120 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 867 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2016 | 44 | 0.120 |
Why?
|
| Ischemia | 1 | 2016 | 158 | 0.110 |
Why?
|
| Positron-Emission Tomography | 2 | 2016 | 298 | 0.110 |
Why?
|
| Odds Ratio | 1 | 2016 | 567 | 0.110 |
Why?
|
| Heel | 1 | 2014 | 7 | 0.110 |
Why?
|
| Speech Recognition Software | 1 | 2014 | 3 | 0.110 |
Why?
|
| Time Management | 1 | 2014 | 4 | 0.110 |
Why?
|
| Efficiency | 1 | 2014 | 33 | 0.110 |
Why?
|
| Databases as Topic | 1 | 2014 | 38 | 0.110 |
Why?
|
| Electronic Mail | 1 | 2014 | 19 | 0.100 |
Why?
|
| Computer Security | 1 | 2014 | 20 | 0.100 |
Why?
|
| Confidentiality | 1 | 2014 | 44 | 0.100 |
Why?
|
| Workload | 1 | 2014 | 48 | 0.100 |
Why?
|
| Systole | 1 | 2014 | 71 | 0.100 |
Why?
|
| Pregnancy, Abdominal | 1 | 2013 | 8 | 0.100 |
Why?
|
| Writing | 1 | 2014 | 46 | 0.100 |
Why?
|
| Thrombosis | 1 | 2016 | 250 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1212 | 0.100 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 20 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2014 | 85 | 0.100 |
Why?
|
| Rectum | 1 | 2013 | 55 | 0.100 |
Why?
|
| Animals | 3 | 2024 | 13526 | 0.100 |
Why?
|
| Rectal Neoplasms | 1 | 2013 | 51 | 0.100 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2012 | 17 | 0.090 |
Why?
|
| Radiology | 1 | 2014 | 137 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 133 | 0.090 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2012 | 23 | 0.090 |
Why?
|
| Multiple Myeloma | 3 | 2016 | 3082 | 0.090 |
Why?
|
| Internet | 1 | 2014 | 265 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 190 | 0.090 |
Why?
|
| Defecography | 2 | 2021 | 16 | 0.090 |
Why?
|
| Liver Failure, Acute | 1 | 2011 | 57 | 0.090 |
Why?
|
| Acetylcysteine | 1 | 2011 | 104 | 0.090 |
Why?
|
| Hepatitis C | 1 | 2012 | 82 | 0.090 |
Why?
|
| Aged | 5 | 2024 | 10429 | 0.090 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 110 | 0.080 |
Why?
|
| Ultrasonography | 2 | 2013 | 426 | 0.080 |
Why?
|
| Ventricular Function, Left | 1 | 2012 | 178 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 501 | 0.080 |
Why?
|
| Mass Screening | 1 | 2013 | 362 | 0.080 |
Why?
|
| Phlebography | 1 | 2010 | 55 | 0.080 |
Why?
|
| Risk Factors | 2 | 2016 | 4017 | 0.080 |
Why?
|
| Endosonography | 1 | 2010 | 98 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 1219 | 0.080 |
Why?
|
| Syndrome | 1 | 2010 | 248 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2010 | 91 | 0.080 |
Why?
|
| Acetaminophen | 1 | 2011 | 277 | 0.070 |
Why?
|
| HIV Infections | 1 | 2012 | 402 | 0.070 |
Why?
|
| Telemedicine | 1 | 2014 | 512 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 645 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 3494 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2318 | 0.060 |
Why?
|
| Extremities | 1 | 2024 | 36 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 58 | 0.050 |
Why?
|
| Phospholipids | 1 | 2022 | 59 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2022 | 99 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2022 | 233 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2013 | 774 | 0.040 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2018 | 14 | 0.040 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2018 | 11 | 0.040 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2018 | 25 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 2018 | 69 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 137 | 0.030 |
Why?
|
| Myoblasts, Skeletal | 1 | 2017 | 10 | 0.030 |
Why?
|
| Soft Tissue Injuries | 1 | 2017 | 17 | 0.030 |
Why?
|
| Fibula | 1 | 2017 | 23 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 65 | 0.030 |
Why?
|
| Tibial Fractures | 1 | 2017 | 34 | 0.030 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2016 | 13 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 91 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2016 | 51 | 0.030 |
Why?
|
| Angiography | 1 | 2016 | 114 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 187 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 181 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2016 | 90 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 246 | 0.030 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 89 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 445 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 487 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 598 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 275 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 659 | 0.030 |
Why?
|
| Delegation, Professional | 1 | 2014 | 1 | 0.030 |
Why?
|
| Online Systems | 1 | 2014 | 8 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2016 | 174 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2017 | 681 | 0.030 |
Why?
|
| Search Engine | 1 | 2014 | 11 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2014 | 42 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2014 | 63 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2013 | 66 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 947 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 975 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 62 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 132 | 0.020 |
Why?
|
| Echocardiography | 1 | 2016 | 409 | 0.020 |
Why?
|
| United States | 2 | 2014 | 5409 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 107 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 274 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2013 | 158 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2014 | 488 | 0.020 |
Why?
|
| Gestational Age | 1 | 2013 | 394 | 0.020 |
Why?
|
| Expectorants | 1 | 2011 | 14 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 1557 | 0.020 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2012 | 35 | 0.020 |
Why?
|
| Patient Selection | 1 | 2013 | 273 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2012 | 109 | 0.020 |
Why?
|
| Antidotes | 1 | 2011 | 27 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 66 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 1368 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 89 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2013 | 278 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 815 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2012 | 203 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2012 | 150 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2011 | 120 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 630 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 273 | 0.020 |
Why?
|
| Smoking | 1 | 2013 | 526 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 2608 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 5982 | 0.010 |
Why?
|